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ABSTRACT
Objectives: To describe the design and baseline
population characteristics of an adapted lifestyle
intervention trial aimed at reducing weight and
increasing physical activity in people of Indian and
Pakistani origin at high risk of developing type 2
diabetes.
Design: Cluster, randomised controlled trial.
Setting: Community-based in Edinburgh and Glasgow,
Scotland, UK.
Participants: 156 families, comprising 171 people
with impaired glycaemia, and waist sizes ≥90 cm
(men) and ≥80 cm (women), plus 124 family
volunteers.
Interventions: Families were randomised into either
an intensive intervention of 15 dietitian visits providing
lifestyle advice, or a light (control) intervention of four
visits, over a period of 3 years.
Outcome measures: The primary outcome is a
change in mean weight between baseline and 3 years.
Secondary outcomes are changes in waist, hip, body
mass index, plasma blood glucose and physical
activity. The cost of the intervention will be measured.
Qualitative work will seek to understand factors
that motivated participation and retention in the trial
and families’ experience of adhering to the
interventions.
Results: Between July 2007 and October 2009, 171
people with impaired glycaemia, along with 124 family
volunteers, were randomised. In total, 95% (171/196)
of eligible participants agreed to proceed to the 3-year
trial. Only 13 of the 156 families contained more than
one recruit with impaired glycaemia. We have recruited
sufficient participants to undertake an adequately
powered trial to detect a mean difference in weight of
2.5 kg between the intensive and light intervention
groups at the 5% significance level. Over half the
ARTICLE SUMMARY
Article focus
▪ Randomised controlled trial.
▪ Diabetes prevention via weight loss and physical
activity.
▪ South Asians living in Scotland, UK.
Key messages
▪ The worldwide prevalence of type 2 diabetes has
doubled over the past 25 years and South Asians,
including those in the UK, are at particularly high
risk of developing the disease.
▪ PODOSA is one of the first community-based, ran-
domised lifestyle intervention trials focusing on the
UK South Asian population, and it is taking place
in Scotland, UK.
▪ The dietitian-led intervention is family focused,
based in the home and is culturally adapted from
the Finnish Diabetes Prevention Study, for people
of Indian and Pakistani origin.
▪ The primary outcome is weight change over
3 years, the main driver for prevention or delay of
onset of type 2 diabetes. The trial is on course to
report in 2013.
Strengths and limitations of this study
▪ The study is one of the few randomised trials
specifically for an ethnic minority population in
the UK.
▪ The results should provide valuable evidence for
tackling the high levels of diabetes in UK South
Asians.
▪ The study could not recruit sufficient people to
examine progression to diabetes within the original
time frame, but it is planned do this over the longer
term via data linkage to national health records.
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families include family volunteers. The main participants have a
mean age of 52 years and 64% are women.
Conclusions: Prevention of Diabetes & Obesity in South Asians
(PODOSA) is one of the first community-based, randomised lifestyle
intervention trials in a UK South Asian population. The main trial
results will be submitted for publication during 2013.
Trial registration: Current controlled trials ISRCTN25729565
(http://www.controlled-trials.com/isrctn/).
BACKGROUND
Diabetes mellitus is a serious disease that reduces life
expectancy by around 6 years from middle age,1 and
increases the risk of blindness, heart disease, stroke and
kidney failure. The age-standardised prevalence of diabetes
worldwide was over 9% (9.8% for men, 9.2% for women)
in 2008. This translates to around 347 million people with
diabetes globally, more than double the number from
1980 (153 million).2 Estimates show that, in India, the
number of adults with diabetes will increase from
50 million in 2010 to at least 87 million by 2030.3 In the
UK, in 2010, there were an estimated 3.4 million people
with type 2 diabetes mellitus (henceforth diabetes), result-
ing in direct costs to the National Health Service (NHS) of
£8.8 billion.4 The adult age-standardised prevalence of dia-
betes in UK South Asians (deﬁned here as UK residents
with ancestral origins in the Indian Subcontinent) is about
2–6 times that of the general population with probably
higher progression rates from impaired glycaemia to dia-
betes, although robust data are lacking.5–7
There is clear evidence from a number of diabetes pre-
vention trials in adults at elevated risk for diabetes that life-
style intervention focusing on modest weight loss (5–10%
of body weight) and increased physical activity is effective
at preventing or delaying diabetes.8–10 Such interventions
have been found to be effective in a number of ethnic
groups including ‘Asians’ living in the USA10 and Indians
living in India.11 The evidence from randomised trials has
been summarised and published by the Centres for
Disease Control and Prevention Primary Prevention
Working Group (2004).12 They conclude that mainten-
ance of moderate weight loss through diet and physical
activity reduces the incidence of diabetes by 40–60% over
3–4 years. A review of evidence and application in a UK
setting by Davies et al
13
showed that major beneﬁts accrue
from 5% to 10% body weight loss and 150 min/week of
physical activity, similar in intensity to brisk walking. They
suggest a need to develop and evaluate interventions that
target communities and populations at risk in the UK.
In the UK, the ﬁrst standard of the National Service
Framework for Diabetes (NSFD) is to reduce the
number of people who develop diabetes and to reduce
inequalities in this disease. The NSFD14 and the Scottish
Government Diabetes Action Plan 201015 place
emphasis on the need to prevent and control diabetes
in the UK’s minority ethnic populations (highlighting
the high rates in South Asians) through implementation
of effective and culturally relevant interventions. The
main risk factors for diabetes, principally weight gain
and physical inactivity, need to be tackled in these popu-
lations, but there are no UK trial data to guide either
practice or policy.
The current challenge is to adapt existing interventions
to meet the cultural needs of South Asians, and to demon-
strate efﬁcacy in the UK context, as it has been suggested
that strategies that work in some societies may not work in
others, as different social, economic, political and cultural
environments will affect diet and lifestyle.13 We based
the Prevention of Diabetes & Obesity in South Asians
(PODOSA) trial on the Finnish Diabetes Prevention study,
which demonstrated the effectiveness of an individual-
focused behavioural intervention that promoted weight
loss and increased physical activity in preventing diabetes
in a general population.9 PODOSA’s key adaptations are
to shift the emphasis from the individual to the family and
from the clinic to the household. A cluster design was
chosen ﬁrst to maximise participation and help achieve
behaviour change, by recognising the fact that most
health-related behaviours take place within the family or
home setting and that other family members may, for
example, be involved in food preparation (supplementary
information in the NSFD).14 Second, this design would
limit potential ‘contamination’ where close members of a
family were in different arms of the trial, but sharing infor-
mation. For reasons already described,16 17 recruitment
proved difﬁcult and the primary aim was changed from a
reduction in the incidence of diabetes to weight loss, as
this needed a smaller sample size.
The PODOSA trial thus aims to test the effectiveness and
cost-effectiveness of an intervention designed to reduce
weight and increase physical activity in adults at high risk of
diabetes, indicated by Impaired Glucose Tolerance (IGT)
or Impaired Fasting Glycaemia (IFG), thereby preventing
or delaying diabetes. The aim of this paper was to describe
the trial design and methods and baseline characteristics of
participants and family volunteers.
METHODS/DESIGN
Study design and questions
PODOSA is a cluster, randomised controlled trial, the
‘cluster’ represented by a family. The original protocol
written in 2007 was designed to answer the primary
question, ‘Does a family-based three-year programme
promoting weight loss and increased physical activity in
South Asians, modelled on interventions of proven
effectiveness internationally, reduce the incidence of
type 2 diabetes in South Asians?’ However, owing to
recruitment challenges,16 a substantial amendment was
approved by the ethics committee in 2009 to alter the
primary outcome as detailed above.
The principal research questions that we are pursuing
are therefore now:
▸ Does a family-based 3-year programme promoting
weight loss and increased physical activity in South
Asians with IGT and/or IFG, modelled on
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interventions of proven effectiveness internationally,
result in a clinically meaningful weight loss in the
intensive intervention (15-visit) group compared with
the light intervention (four-visit) group?
▸ What is the cost-effectiveness of the intervention?
▸ What factors assist recruitment, adherence to advice
given and retention in the trial?
In addition to participants with impaired glycaemia, we
invited adult members of their families to take part, mainly
to support the trial participants in the process of lifestyle
change. We made limited measurements on the family
volunteers both to motivate them in changing their own
lifestyles and to help assess the potential beneﬁts to family
members outside the main intervention groups.
The secondary research questions which are designed
to help interpret the main outcomes are:
▸ During the trial, what changes occur over time
among participants with IGT and/or IFG, and
volunteer members of their families (analysed
separately), in
– Waist circumference?
– Hip circumference?
– Fasting and 2 h blood glucose (IGT/IFG recruits
only)?
– Incidence of type 2 diabetes presently (and in the
longer term, to be assessed via data linkage)?
The primary outcome is mean weight change between
baseline and 3 years. Our goal is weight loss of 2.5 kg
more (or 2.5 kg lower weight gain) in the intensive inter-
vention than in the light intervention group and
increase in physical activity to at least 30 min daily.
Ideally, we would reduce the body mass index (BMI) to
at least 25 or preferably 23 (the interim WHO recom-
mendation for Asian populations).18
Secondary outcome measures of interest are:
▸ Mean changes between baseline and 3 years in waist
and hip circumference, BMI, fasting and 2 h
post-Oral Glucose Tolerance Test (OGTT) glucose;
▸ Cost-effectiveness of the intervention (focusing on
health service costs of the intervention and the
opportunity cost of time for trial participants);
▸ Progression to type 2 diabetes in the longer term.
For the volunteer members of the family, these are:
▸ Mean changes between baseline and 3 years in
weight, BMI and waist and hip circumference.
Ethical approval
Ethical approval was obtained from the Scotland A
Research Ethics Committee. All recruits gave written,
informed consent to take part in the screening stage of
the study and then further written consent for participa-
tion in the 3-year trial.
Setting and recruitment
Recruitment took place between July 2007 and October
2009. Men and women of Indian and Pakistani origin,
aged 35 years and over, and living in the Lothian and
Greater Glasgow & Clyde Health Board areas, were
invited to be screened with the (OGTT).
Eligibility criteria
Eligible participants for the trial were those with
▸ Waist sizes ≥90 cm for men and ≥80 cm for women;
▸ IGT (ie, fasting plasma glucose of <7 mmol/l and, fol-
lowing a standard OGTT, a 2 h plasma glucose of
7.8–11.0 mmol/l);
▸ IFG (ie, plasma fasting glucose of 6.1–6.9 mmol/l);
▸ No previous diagnosis of diabetes;
▸ ‘Family cook’ agreed to cooperate (whether a family
volunteer or another family member).
Participants on prescribed long-term oral corticoster-
oids, suffering from a health condition where adherence
to the intervention was contraindicated or improbable,
or unlikely to remain in the UK for 3 years, were
excluded from trial entry.
The waist criteria correspond to the cut-off points
recommended by the International Diabetes Federation
Consensus Group in 2005 to identify South Asians at risk
of diabetes.19
Eligible family volunteers were
▸ ≥18 years of age;
▸ Close relative of the IGT/IFG participant either
living within the same household, or living nearby
and interacting with main recruit(s) on at least a
weekly basis.
Definition of a family (cluster)
The composition of families was established in consult-
ation with the family itself. Criteria were deﬁned to identify
each extended family unit prior to randomisation. To min-
imise contamination, ﬁrst-degree relatives (parents, sib-
lings, children) living in the same city could not be
randomised separately. The cluster is ‘the core family’ con-
sisting of the participant(s) with IGT/IFG, plus any family
volunteer(s). In practice, given the relatively low preva-
lence of IGTor IFG (15%), compared with 30% expected,
clustering was less common than predicted.
Sample size considerations
In the original study design, it was anticipated that there
would often be at least two eligible individuals per
family (ie, per cluster), so the fact that we were using a
cluster randomised design was critical in the power cal-
culation. However, when the primary endpoint was
amended to weight change, it was clear that the vast
majority of ‘clusters’ would comprise a single individual.
Thus, in practice, the impact of clustering will be negli-
gible, and the modiﬁed power calculation did not take
this into account. The target sample size for the
amended trial was calculated to be 175 recruits to allow
for a 10% drop-out. This would result in at least 150
recruits having complete follow-up at 3 years. This
sample size gives adequate (86%) power to detect a dif-
ference of 50% of the SD (ie, a mean difference in
weight change of 2.5 kg between the two groups
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against a common background SD of 5 kg, derived
using nQuery Advisor V.7.0) at the 5% signiﬁcance
level (two-sided).
Randomisation and allocation of interventions
Randomisation lists were produced by the trial statistician
using a random number generator programme. Permuted
blocks were used and block size varied randomly.
Stratiﬁcation was by location (Edinburgh or Glasgow),
ethnic group (Indian or Pakistani) and number of
IGT/IFG recruits in the family (one or more than one).
All members of a ‘family’ gave written informed consent
and completed the baseline visit prior to randomisation.
Allocation of the intervention group was then performed
centrally, by the trial statistician or a deputy, independently
from the dietitians and trial ofﬁce staff. This strategy was
implemented to minimise selection bias during the
recruitment process and meant that both the dietitians
and the families did not know the allocated intervention
until the enrolment and baseline measurements had been
completed. As in other lifestyle prevention trials, blinding
of the intervention was not feasible.
The study has two groups for comparison, one group
having more frequent and tailored contact (intensive or
15-visit intervention) with the research dietitians than
the ‘control’ group (light or 4-visit intervention), which
largely receives information. The 15-visit group of 78
families received 15 contacts over 3 years, monthly for
3 months and quarterly thereafter. The four-visit group
of 78 families had annual contact over 3 years with the
dietitian. The dietitians visited the participating families
at their home or community setting of their choice.
Measurements and data collection
Prior to the start of recruitment, pilot work was carried
out for the main trial procedures, covering consent,
measurements and OGTT, and the screening and base-
line visits. Table 1 outlines the time-points for consent,
randomisation and collection of data for the main trial
outcomes for all trial participants. Anthropometric mea-
surements, background and outcome data were col-
lected by the dietitians in the case record forms at each
visit. Standard operating procedures were written for all
the main study procedures including anthropometric
measurements and the oral glucose tolerance test. Two
measurements for height, weight, waist and hip were
performed and if the difference was more than a speci-
ﬁed value (height, waist and hip >1 cm, weight >0.2 kg),
a third measurement was carried out. Physical activity
was assessed by the short form of the International
Physical Activity Questionnaire (IPAQ).20 Time spent
sitting, walking and undertaking moderate and vigorous
activities was extracted from the IPAQ with time spent
walking and in moderate and vigorous activities trun-
cated at 180 min/day, in line with the published IPAQ
data processing guidelines (http://www.ipaq.ki.se).
Data were entered by the study assistant into a
Microsoft Access database which has inbuilt validity and
consistency checks. Subsequent data cleaning was per-
formed by further manual and statistical checking.
Double data entry was carried out for the key variables
relating to the main trial outcomes, including random-
isation criteria, all anthropometric and biomedical mea-
sures and demographic and health economics data.
Three of four research dietitians were employed
throughout the full study period and followed up the fam-
ilies for the full 3 years. The fourth dietitian left the
research team in 2009 and her families were distributed
among the remaining three dietitians. To counteract any
potential observer bias when recording the key endpoint
variables at the 3-year visits, an independent set of
anthropometric measures (in addition to those recorded
by the dietitians) was recorded by trained research nurses
blinded to the study group.
Measurements for volunteer members of the family
As shown in table 1, weight and waist and hip circumfer-
ences were measured annually in adult family volunteers
with and without diabetes (no blood tests were performed).
Intervention for 15-visit group
The research dietitians were trained in venepuncture,
measurement, delivery of information, behaviour change
and promotion of physical activity. The contacts with the
families were, in effect, the intervention, and in general,
each family was seen by the same dietitian for the duration
of the trial. The content of the contacts was tailored, using
a range of culturally adapted change management tools,
to the needs of the individuals and families. The dietitians
motivated the participating families to achieve weight loss
through a calorie deﬁcit diet in conjunction with physical
activity. Verbal and written advice was provided including
information on shopping, cooking (with demonstrations)
and entertaining. Participants were invited to annual
group sessions consisting of a food shopping tour, under-
standing food labels, exchange of recipes, food tasting and
brisk walking. The dietitians’ toolkit (which will be pub-
lished on the PODOSA website, http://www.podosa.org,
by the end of March 2013), contained culturally adapted
and translated existing resources on diet and physical
activity such as Counterweight.21 A paper on the cultural
adaptation process of the study materials has been
accepted for publication (subject to minor revisions) by
Health Promotion International. Pedometers were integral
to the physical activity programme, providing motivation
through self-monitoring and a tool for the dietitians to
assess progress. Daily food diaries and pedometer logs,
body weight and waist circumference data and the Chester
Step Test22 were used as educational and motivational
tools by the dietitians.
Intervention for four-visit group
This group had a baseline and then annual contact with
the research dietitian. The dietitians gave both written
and verbal advice on healthy eating, diabetes prevention,
promotion of physical activity and on accessing available
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Table 1 Time points of outcome measures and data collection
Time point
(months)
Name of
visit
Informed
consent
OGTT & blood
sample for
storage
Anthropometric
measurements
Demographic,
socioeconomic
self-reported medical
history
Costs and
health
resource use
Physical
activity
data
Delivery of intervention
(intensive or light)
–1* Screen ✓ ✓ ✓
0*† Baseline ✓† ✓† ✓ ✓ ✓ General information on
diabetes, diet and physical
activity to all participants
0*† (plus
1 week)
Family (as the cluster) randomised to 15 or four-visit group
1 Interim ✓ ✓ ✓
2 Interim ✓ ✓ ✓
3 Interim ✓ ✓ ✓
6 Interim ✓ ✓ ✓
9 Interim ✓ ✓ ✓
12*† Annual ✓† ✓ ✓ ✓ Intensive or light
15 Interim ✓ ✓ ✓
18 Interim ✓ ✓ ✓
21 Interim ✓ ✓ ✓
24*† Annual ✓ † ✓ ✓ ✓ Intensive or light
✓ ✓ ✓
27 Interim ✓ ✓ ✓
30 Interim ✓ ✓ ✓
33 Interim ✓ ✓ ✓
36*† Annual ✓ (OGTT
repeated if
positive for
diabetes)
✓† ✓ ✓ ✓ Intensive or light
*Measurements and data collected similarly for participants in intervention and control groups—or prior to randomisation.
†Indicates time points and data collection for Family Volunteers.
OGTT, Oral Glucose Tolerance Test.
Douglas
A,BhopalRS,BhopalR,etal.BM
J
Open
2013;3:e002226.doi:10.1136/bm
jopen-2012-002226
5
D
e
s
ig
n
a
n
d
b
a
s
e
lin
e
c
h
a
ra
c
te
ris
tic
s
o
f
th
e
P
O
D
O
S
A
tria
l
 
group.bmj.com
 o
n
 February 27, 2013 - Published by 
bmjopen.bmj.com
D
ow
nloaded from
 
health services for weight control and physical activity.
The research team agreed which resources should be
given to families in the four-visit group at each visit, to
ensure consistency. Although these actions were better
than the routine service, it is not anticipated that they
will reduce weight substantially and sustainably, though
they may stabilise it and counteract the secular trend
and age effects of increasing weight.23 In our opinion,
this level of intervention was necessary on ethical
grounds. It also offered something in return for partici-
pation and measurements.
Measurement and valuation of costs
The PODOSA trial design included an integrated cost ana-
lysis. Cost data were collected prospectively from random-
isation (baseline) to the 3-year follow-up. We chose a
societal perspective for the analysis which encompassed
the health service costs of the intervention and the oppor-
tunity cost of time for trial participants. The programme
costs included the number and length of home visits by
research dietitians and self-reported health service use in
primary and acute care settings. Initial screening and trial
recruitment costs were excluded. We valued dietitians’
time (face-to-face contact, previsit and postvisit review and
travel to participants’ households) using NHS salary scales
inclusive of salary on-costs and overheads. Standard NHS
unit costs were used to value general practitioner visits and
hospital out-patient clinic attendances. Participant time
included the number and length of dietitian visits and self-
reported time spent doing moderate physical activities and
on household allocation of time for food shopping and
meal preparation. Median hourly wages by gender and
ethnicity reported by the National Equality Panel/Labour
Force Survey24 were used to value participant time. No esti-
mate of diet costs was included. The present value of the
3-year cumulative costs was calculated using a 3.5% annual
rate of discount following the UK Treasury and National
Institute for Health and Clinical Excellence (NICE) guid-
ance. All costs are reported in UK pounds using 2010 pay
and price levels.
All analyses will be conducted on an intention-to-treat
basis. The conditional mean cost comparison between
15-visit and 4-visit groups will be modelled using linear
regression and generalised linear parametric methods.
The mean cost difference between the groups will also
be assessed using a non-parametric bootstrap. Quantile
regression will be used to examine and compare the
median cost differences. The relatively small sample size
precludes assessment of heterogeneous treatment effects
or subgroup differences in costs.
The robustness of results will be investigated by using
a strategy of comparing different speciﬁcations within
the generalised linear model and conducting a series of
one-way sensitivity analyses, where we will alter key
assumptions on programme intensity and frequency as
measured by the number, length and duration of visits.
The cost implications arising from moving away from a
one-to-one programme towards a group-based interven-
tion will also be considered.
Qualitative study
An embedded qualitative study was undertaken to:
▸ Obtain a rich and multifaceted understanding of the
main motivations for participation in an intervention
study of Indian and Pakistani adults who are at high
risk of developing diabetes.
▸ Investigate participants’ perceptions of ﬁdelity and
faithfulness to the interventions offered both during
and after participation.
▸ Understand the factors that may help promote reten-
tion of participants once enrolled.
We utilised the storytelling concept to collect narra-
tives describing the live experiences of participation in
PODOSA from families at completion of the trial. The
objective was to try to understand what factors motivate
the ethnic minority people to engage with research and
to understand more about the facilitators to participa-
tion through understanding the perspectives and experi-
ences of those who chose to participate in the trial.
A detailed description of our methods will be reported
in due course, but in summary, we undertook purposeful
sampling on the basis of age, sex, ethnicity, faith group,
geographical location and trial arm to ensure recruitment
of a maximum diversity sample. We also sought to include
family volunteers when possible. Biographical narrative
interviews were undertaken usually in participants’ homes
and in their preferred language, with the aid of a transla-
tor, if necessary. These interviews were digitally recorded,
translated (if necessary) and then transcribed together
with accompanying ﬁeld notes. Analysis was undertaken in
an iterative fashion, thus informing of further data collec-
tion. Thematic and performance analysis25 of the data uti-
lised the constant comparison method26 concurrent to
data generation, utilising NVivo9 software to code data
during analysis.
Laboratory assessments
The 75 g OGTT followed standardised procedures, with
venous blood samples being taken after an overnight fast
of 10–16 h and then 2 h after ingestion of 75 g glucose.
Samples were then transported to a central hospital
laboratory (Western General Hospital, Edinburgh or
Glasgow Royal Inﬁrmary) where plasma glucose concen-
tration was determined using the Ortho clinical diagnos-
tics, Fusion dry ice method (Edinburgh), or the Abbott
Architect, hexokinase/glucose-6-phosphate dehydrogen-
ase method (Glasgow). Both laboratories participate in
the UK National External Quality Assessment Service
(UK NEQAS) scheme. In addition, an EDTA sample was
obtained from all recruits at baseline and at 3 years, and
with the participant’s speciﬁc informed consent, plasma
and DNA aliquots stored at –80°C, for future analyses
out with the remit of the current trial.
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Statistical analysis
Analyses will be performed on an intention-to-treat basis,
that is, participants will be analysed in the group that they
were assigned to regardless of how much of the interven-
tion they received, unless speciﬁed otherwise.
Owing to the clustering inherent in the design, the
primary outcome will be analysed using a random effects
linear regression model (to accommodate the clustering of
individuals within families) with maximum likelihood esti-
mation. The model will be adjusted for the stratiﬁcation
variables (ethnicity and location). Change over time will be
incorporated into the model using an extension to the ana-
lysis of covariance approach, adjusting for baseline value.
Treatment group will be included in the model as a ﬁxed
effect. Results will be reported as an adjusted (for ethnicity
and location) mean difference in weight between baseline
and 3 years, with a 95% CI and corresponding p value. The
intraclass correlation coefﬁcient will be reported.
Analyses of secondary outcomes will mirror those for
the primary outcome, where the distribution of the rele-
vant outcome is continuous. Where the outcome is a
proportion, the approach will be to ﬁt a generalised
linear mixed model with terms for stratiﬁcation variables
and treatment group as above and adjusting for baseline
value where applicable. Results will be reported as an
adjusted OR with a 95% CI and corresponding p value.
RESULTS
Recruitment
As shown in ﬁgure 1, 1319 participants were screened
with an OGTT over a 27-month period between July
2007 and October 2009. In total, 102 recruits (8%) had
OGTT results indicative of diabetes and 196 (15.4%)
were found to have impaired glycaemia. Sixteen partici-
pants did not meet eligibility criteria to proceed into the
full trial and nine declined to participate further. Thus,
95% (171/196) agreed to continue into the 3-year trial.
In total, 156 family clusters comprising the 171 eligible
participants with IGT and/or IFG, along with 124 family
volunteers, were randomised into either the 15-visit or
4-visit intervention groups.
Baseline characteristics of the trial population
Baseline characteristics are shown in table 2. The fam-
ilies range from single participants to a family compris-
ing four IGT/IFG recruits with ﬁve family volunteers.
Only 13 of the 156 trial families have more than one
recruit with IGT/IFG. Family volunteers were recruited
to 85 families. The trial population is well established in
the UK with a mean residency time of around 31 years.
Approximately 33% of the participants have no formal
educational qualiﬁcations.
Figure 1 PODOSA (Prevention
of Diabetes & Obesity in South
Asians) trail consort flowchart.
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Table 2 shows that approximately 84% of family cooks
are either the IGT/IFG person or a family volunteer.
The remainder all agreed to cooperate. Over a third of
the participants had a close family history of diabetes.
Part (c) of table 2 describes the lifestyle characteristics
of the participants. The average total activity time (com-
prising vigorous, moderate and brisk walking) for the
trial population was 51 min/day. The mean sitting time
was 6.5 h/day.
The mean BMI for all recruits was 30.5 kg/m2, and
overall, 49% of participants had BMI >30 kg/m2. Table 3
shows demographic and anthropometric characteristics
of the 124 family volunteers. Most volunteers were
female (77%) and 64/124 (52%) were the spouse or
partner of the index recruit. Over 90% of the family
volunteers were recruited in Glasgow. The mean BMI of
family volunteers was 27.4 kg/m2.
DISCUSSION
Principal achievements
The PODOSA trial’s key achievements include: establish-
ing the infrastructure for the trial; recruiting, training
and forging a multiethnic team to implement the trial;
and the involvement and support from within the wider
South Asian community, particularly in the recruitment
phase.17 It was encouraging that 95% of eligible recruits
consented to participate in the 3-year trial (171/196).
We emphasised the need for family involvement as a
means of motivating behaviour change and set the
complex intervention in the home setting. Our only
entry criterion relating to the family was that the main
cook agree to co-operate, and this was always achieved.
We consider this a major success. It proved harder to
recruit family volunteers in Edinburgh than in Glasgow.
It was difﬁcult to identify clear reasons for this, but the
dietitians reported that, in many instances, the potential
volunteers were either unavailable or did not interact or
eat with the main recruits with sufﬁcient frequency.
The proportion of Pakistani to Indian recruits (2:1) in
PODOSA closely reﬂects the wider resident South Asian
population as reported in the 2001 Scottish census
where those of Pakistani origin represented 31% of
the total minority ethnic population and 15% were of
Indian origin.27
Strengths and weaknesses
PODOSA, to our knowledge, is one of the ﬁrst culturally
adapted, community-based, randomised intervention
trials on lifestyle and health issues in South Asians in the
UK. PODOSA will contribute evidence for weight
control and diabetes speciﬁcally; however, its long-term
legacy will be the experience, lessons and example of
the evaluation of complex interventions in ethnic minor-
ity populations set in the community in the UK multi-
ethnic society.
Although we were unable to recruit sufﬁcient
numbers to examine, with sufﬁcient power, progression
to diabetes within the life of the trial, we have
participants’ consent to link trial data to the Scottish
national morbidity records and Scottish diabetes register
during a 10-year follow-up period. This may allow ana-
lysis of this outcome in the longer term. However,
weight loss, our new primary outcome, is the main
driver for diabetes prevention, and physical activity, a
secondary outcome, is also important.
Putting the study in context
Based on the available evidence in 2005 at the design stage
of the trial,5 19 we set eligibility criteria for waist circumfer-
ence (≥90 cm for men and ≥80 cm for women) as those
with central obesity are more likely to have impaired gly-
caemia. We estimated that we would identify IGT in around
30% of such volunteers screened for trial eligibility.5
Within PODOSA, the prevalence rate for IGT and/or IFG
was approximately 15%, much lower than expected. The
Leicester (UK) Addition study reported ﬁnding 19.8% IGT
or IFG in South Asians aged 40–75 years, with no
minimum waist size.28 A recent systematic review29 of cross-
sectional studies in South Asians also suggests a stable or
falling IGT prevalence, although the natural history of pre-
diabetes and its progression to diabetes still remains
unclear. Our lower prevalence rate of impaired glycaemia
was one of the contributory factors to our difﬁculty in
achieving the original intended sample size.
Within the UK, the case for national screening pro-
grammes for both diabetes and impaired glycaemia
remains equivocal.30 Recent research has suggested that
the case is stronger than it was, although evidence from
good quality trials showing a subsequent reduction in mor-
bidity and mortality is still required.31 Hanif et al
32
argue
that a stepwise screening strategy aimed at the South Asian
population could be effective, although further work is
needed to examine implementation within primary care.
The Addition Leicester trial,6 a community screening pro-
gramme and cardiovascular risk intervention, includes a
signiﬁcant South Asian population and is due to report in
2013. The results from PODOSA, also expected in 2013,
will contribute to urgently needed evidence about the
effectiveness of prevention interventions in a UK ethnic
minority population at high risk of developing diabetes.
Implications
South Asians are at high risk of developing type 2 dia-
betes and effectiveness data for culturally tailored health-
care interventions are urgently required in order to help
prevent this epidemic and to help inform healthcare ser-
vices and policy in the UK. The trial results, including
cost-effectiveness and qualitative ﬁndings, will be submit-
ted for publication in 2013. In particular, this study has
focused on the family rather than the individual and
moved from the traditional clinic to a home setting.
This kind of approach has been promoted in guidance
from NSFD and NICE,14 33 so evidence from PODOSA
will be pertinent to this line of argument. More gener-
ally, PODOSA will also contribute to the evidence base
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for conducting randomised lifestyle intervention trials in
ethnic minority populations in the UK and contribute to
future meta-analyses with ongoing diabetes prevention
trials in other South Asian populations.
Table 2 Recruits with IFG and/or IGT, demographic,
social, lifestyle, anthropometric, biochemical and other
background characteristics of trial participants
Variables
All participants
number (column %)
Demographic
Number of families with
1 IGT/IFG recruit 143 (91.7)
2 IGT/IFG recruits 12 (7.7)
4 IGT/IFG recruits 1 (0.6)
Number of families with
With family volunteer(s) 85 (54.5)
Number of IGT/IFG individuals 171 (100)
Number of family volunteers 124 (100)
Individual IGT/IFG recruits
Sex—male 78 (45.6)
Age—mean (SD) 52.3 (10.1)
Age—range 35–80
Location
Glasgow 132 (77.2)
Edinburgh 39 (22.8)
Ethnic group
Indian 57 (33.3)
Pakistani 114 (66.7)
Religion
Muslim 114 (66.7)
Hindu 15 (8.8)
Sikh 39 (22.8)
Other 3 (1.8)
Social circumstances
Cook was a participant 85 (49.7)
Cook was a family volunteer 59 (34.5)
Cook was simply cooperating 27 (15.8)
Blood relative with diabetes 118 (69.0)
Years lived in UK
(mean, SD)
31.4 (13.1)
Education
No qualifications 56 (32.7)
School level 49 (28.7)
Further or higher education 66 (38.6)
Lifestyle
Current smoking/chewing
tobacco
11 (6.4)
Currently drinks alcohol 19 (11.1)
Vegetarian 26 (15.2)
Physical activity (mean minutes per day, SD)
Total (moderate, vigorous,
walking)
51.0 (61.0)
Moderate and vigorous only 23.3 (44.7)
Walking only 27.7 (37.1)
Sitting time (mean hours per
day, SD)
6.5 (3.0)
Anthropometric (values are given as mean and SD)
Height (cm) 161.9 (9.3)
Weight (kg) 80.2 (15.6)
BMI (kg/m2) 30.5 (4.8)
Waist (cm) 103.0 (11.1)
Hip (cm) 107.1 (9.5)
Waist/hip ratio 0.96 (0.07)
BMI <25 (n, %) 20 (11.7)
Continued
Table 3 Family volunteers, Demographic, anthropometric
and other background characteristics of family volunteers
All family volunteers
number (column %)
Demographic
Sex—male 28 (22.6)
Age—mean (SD) 41.9 (14.9)
Age—range 18–75
Location
Glasgow 114 (91.9)
Edinburgh 10 (8.1)
Ethnic group
Indian 42 (33.9)
Pakistani 79 (63.7)
Other 3 (2.4)
Relationship to main recruit
Spouse/partner 64 (51.6)
Parent 2 (1.6)
Son/daughter 26 (21.0)
Brother/sister 5 (4.0)
Other 27 (21.7)
Anthropometric (values are given as mean and SD)
Height (cm) 161.7 (8.5)
Weight (kg) 71.4 (13.9)
BMI (kg/m2) 27.4 (5.3)
Waist (cm) 92.7 (12.4)
Hip (cm) 104.7 (8.6)
Waist/hip ratio 0.89 (0.08)
Biomedical
Number of with diabetes
(self-reported)
15 (12.1)
Figures are numbers and column percentages unless otherwise
stated.
Table 2 Continued
Variables
All participants
number (column %)
BMI ≥25 and <30 (n, %) 67 (39.2)
BMI ≥30 (n, %) 84 (49.1)
Biomedical measures (values are given as mean and SD)
Systolic BP (mm Hg) 136.9 (20.6)
Diastolic BP (mm Hg) 83.0 (11.5)
Fasting plasma glucose (mmol/l) 5.8 (0.6)
2 h post-OGTT plasma glucose
(mmol/l)
8.3 (1.6)
Current medications (n, %)
Antihypertensives 48 (28.1)
Cholesterol lowering 39 (22.8)
Figures are numbers and column percentages unless otherwise
stated.
BMI, body mass index; IFG, Impaired Fasting Glycaemia; IGT,
Impaired Glucose Tolerance; OGTT, Oral Glucose Tolerance Test.
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